Allison Pavlick
Principal at S32 · San Francisco, United States
Invests in AIAllison Pavlick's investor profile lists AI alongside Healthcare & Biotech, Biotech & Pharma and Digital Health & HealthTech, at Series B. No deals are on record yet, so this page lists the startup credits a company at these stages can claim.
Email InvestorCredits to line up before a Series B round
Allison Pavlick backs companies at Series B. A few of the larger credit programs on AI Perks for teams at that point:
Investment focus
- Backs startups in
- Artificial Intelligence, Healthcare & Biotech, Biotech & Pharma, Digital Health & HealthTech
- Rounds
- Series B
- Profile
- Venture investor
- Deals on record
- None yet
- Based in
- San Francisco, United States

Ready to pitch AI investors?
AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.
Email InvestorMore AI investors on AI Perks
- Lonne JaffeManaging Director at Insight Partners
- Adam ValkinManaging Director at Vine Ventures
- Nikitas KoutoupesManaging Director at Insight Partners
- Bryan SchreierVenture investor in Menlo Park
- Amy MathisVenture investor in Metairie
- Rajeev DhamManaging Director at Sapphire Ventures
- Jake MedwellFounding Partner at 8VC
- Dev KharePartner at Lightspeed India
Questions founders ask
- Does Allison Pavlick invest in AI startups?
- Yes. Artificial Intelligence is one of the sectors on Allison Pavlick's investor profile, together with Healthcare & Biotech, Biotech & Pharma and Digital Health & HealthTech. The stages on record are Series B.
- What credits can a startup claim before pitching Allison Pavlick?
- For a company raising a Series B round, AI Perks lists credits such as SendGrid/Twilio (up to $10,000), Atlassian (up to $30,000), Zendesk (up to $100,000) and Mixpanel (up to $50,000), with each program's terms and how to apply.
- Does AI Perks publish investor contact details?
- No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor
Source: public professional information. Is this you? Request removal